Mukka Proteins Limited (MUKKA) Fair Value & Analysis
Consumer Defensive · IN · Market cap ₹7.2B
Fair value as of: Jul 3, 2026
From 14 valuation models · updated today
Share price +6.7% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹18.49 – ₹30.01 · fair‑value band ₹27.34 – ₹51.25 · the ₹23.95 price screens below the ₹39.43 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Mukka Proteins Limited (MUKKA) currently trades at ₹23.95, while our model-based Fair Value estimate is ₹39.43 — implying the stock looks roughly 64.6% undervalued today. We read business quality at 35/100 (below-average quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
Over the trailing twelve months, Mukka Proteins Limited generated revenue of ₹14.5B at a net margin of 3.6%. Revenue declined 0.3% year over year. It earns a return on equity of 11.6%. Net debt stands at ₹7.2B. Fundamentals as of Jul 3, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
About the company
Mukka Proteins Limited manufactures and sells fish protein products in India. The company offers fish meal, oil, and soluble paste; and ento meal, oil, and soil. It also provides insect meal, oil, and compost; and humic acid. The company's products are used for aqua feed, poultry feed, pet feed, EPADHA extraction, animal feed, soap manufacture, leather tanneries, and paint industries. It also exports its products to Bahrain, Bangladesh, Chile, Indonesia, Malaysia, Myanmar, the Philippines, China, Saudi Arabia, South Korea, Oman, Taiwan, and Vietnam. The company was formerly known as Mukka Sea Food Industries Limited and changed its name to Mukka Proteins Limited in August 2021. The company was founded in 1960 and is based in Mangalore, India.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Mukka Proteins Limited reported revenue of ₹14.5B in FY2026 versus ₹7.7B in FY2022, a compound +17.3%/yr. Reported net income was ₹521M in FY2026, compounding +21.1%/yr from FY2022.
Is MUKKA fairly valued? → Check now
Similar stocks
6 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Nestlé S.A NESN | CHF 79.44 | CHF 50.99 | -36% |
| Foshan Haitian Flavouring and Food Company 603288 | ¥34.03 | ¥23.66 | -30% |
| Nestlé India Limited NESTLEIND | ₹1,402 | ₹362.37 | -74% |
| Grupo Bimbo, S.A. BIMBOA | 57.10 MXN | 45.03 MXN | -21% |
| Uni-President Enterprises Corp 1216 | 73.80 TWD | 61.57 TWD | -17% |
| Britannia Industries Limited BRITANNIA | ₹5,171 | ₹1,966 | -62% |
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Mukka Proteins Limited (MUKKA) undervalued?
What is the fair value of MUKKA?
What is the quality score of MUKKA?
What is the revenue of Mukka Proteins Limited (MUKKA)?
What is the net profit margin of MUKKA?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.